1. Academic Validation
  2. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

  • Nat Immunol. 2003 Jan;4(1):69-77. doi: 10.1038/ni875.
Sergei V Kotenko 1 Grant Gallagher Vitaliy V Baurin Anita Lewis-Antes Meiling Shen Nital K Shah Jerome A Langer Faruk Sheikh Harold Dickensheets Raymond P Donnelly
Affiliations

Affiliation

  • 1 Department of Biochemistry and Molecular Biology, UMDNJ-New Jersey Medical School, Newark, NJ 07103, USA. kotenkse@umdnj.edu
PMID: 12483210 DOI: 10.1038/ni875
Abstract

We report here the identification of a ligand-receptor system that, upon engagement, leads to the establishment of an Antiviral state. Three closely positioned genes on human chromosome 19 encode distinct but paralogous proteins, which we designate interferon-lambda1 (IFN-lambda1), IFN-lambda2 and IFN-lambda3 (tentatively designated as IL-29, IL-28A and IL-28B, respectively, by HUGO). The expression of IFN-lambda mRNAs was inducible by viral Infection in several cell lines. We identified a distinct receptor complex that is utilized by all three IFN-lambda proteins for signaling and is composed of two subunits, a receptor designated CRF2-12 (also designated as IFN-lambdaR1) and a second subunit, CRF2-4 (also known as IL-10R2). Both receptor chains are constitutively expressed on a wide variety of human cell lines and tissues and signal through the Jak-STAT (Janus kinases-signal transducers and activators of transcription) pathway. This receptor-ligand system may contribute to Antiviral or other defenses by a mechanism similar to, but independent of, type I IFNs.

Figures